D Schröder-Bernhardi

Validity and representativeness of the “Disease Analyzer” patient database for use in pharmaco-epidemiological and pharmacoeconomic studies

Heiko Becher, Karel Kostev, D Schröder-Bernhardi · International Journal of Clinical Pharmacology and Therapeutics · 2009 · 244 citations

Public Health, Internal Medicine, Pharmacoeconomics +12

Isopropanolic black cohosh extract and recurrence-free survival after breast cancer

Hans‐Heinrich Henneicke‐von Zepelin, H. Meden, Karel Kostev et al. · International Journal of Clinical Pharmacology and Therapeutics · 2007 · 73 citations

Medicine, Oncology, Pharmacology +14

Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study

Joerg Hasford, D Schröder-Bernhardi, Marietta Rottenkolber et al. · European Journal of Clinical Pharmacology · 2007 · 63 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Use of the mediplus® patient database in healthcare research

G Dietlein, D Schröder-Bernhardi · International Journal of Clinical Pharmacology and Therapeutics · 2002 · 33 citations

Health Professions, Biomedical Informatics, Health Informatics +13

Antihypertensive treatment and risk of dementia: a retrospective database study

Andrea Icks, Heinz‐Harald Abholz, D Schröder-Bernhardi et al. · International Journal of Clinical Pharmacology and Therapeutics · 2011 · 31 citations

Medicine, Geriatric Medicine, Pharmacotherapy +15